Issue link: https://viewer.e-digitaledition.com/i/1014440
the same roof as our radiation oncolo- gists to develop individualized treatment pla ns for our patients," says Jeffrey Vainshtein, MD, Medical Director of the Center for Radiosurgery. "Compared with patients who undergo more conventional radiotherapy techniques or invasive sur- gery, patients who have radiosurgery do not require hospitalization and experience minimal effects to surrounding tissues and organs." A hallmark of the Edge is its versatility. It can target lesions ranging from 1-mil- limeter brain tumors using SRS, a type of radiosurgery often reserved for small, localized cancers, especially in the brain, to large tumors affecting a variety of organs using SBRT, which is typically used to treat extracranial tumors. Treatment with the Edge begins with an outpatient consultation between the patient and radiation oncologist, followed by a CT simulation to plan the treatment. "After the simulation, the radiation oncol- ogist works with a team of dosimetrists and physicists to design a treatment plan that offers the best chance of tumor eradication," Dr. Vainshtein says. "The patient returns to the Center for Radiosurgery for a 'dry run' and has the actual treatment the following day. Each treatment takes 15 to 20 min- utes. The Edge rotates around the patient, delivering high-energy X-rays directly to the site of the tumor from a variety of angles. From the patient's perspective, the experience is basically no different from a typical CT scan." Radiosurgery with the Edge also offers a level of convenience unknown to prior generations of radiation oncology patients. Previously, elderly individuals with early- stage lung cancer and comorbid conditions who were not candidates for surgery faced up to nine weeks of five-times-per-week external beam radiation therapy, according to Dr. Vainshtein. "With radiosurgery, we're able to treat these patients — for example, those with early-stage lung cancer who aren't able to undergo surgery, are borderline surgical candidates or decline surgery — in three to five treatments with minima l side effects and tumor ablation rates exceed- ing 90 percent," Dr. Vainshtein says. "For this population, the advent of SBRT has markedly transformed the way we manage early-stage lung cancer." A TREATMENT FOR EVERY TUMOR The Edge was the second of two new linear accelerators to arrive at the Center for Cancer Care in the past year — the first was the TrueBeam Radiotherapy System by Varian. Like the Edge, the TrueBeam is multifunctional — it can per for m i ma ge -g u ided radiotherapy and intensity- modulated radiotherapy as well as SBRT. At the Center for Cancer Care, radiation oncologists typi- cally use the Edge to deliver stereotactic treatments and utilize the TrueBeam for non-stereotactic radiotherapy. "Examples of tumors we treat using the TrueBeam include lung, head and neck, and breast tumors that require larger areas of radiation therapy, as well as colorectal, bladder and advanced prostate tumors," Dr. Stevens says. "Uterine and cervical can- cers are best treated using the TrueBeam, as well." T he brev it y of t reat ment cou rses that radiosurger y and other advanced radiot herapy techniques have made possible is striking. "Radiotherapy courses are shorter now — many are five sessions or fewer, with some as few as one — and that has really changed the face of our department," Dr. Stevens says. "We used to have patients come for radiotherapy for six weeks, on average. Individuals with prostate cancer typically needed nine weeks of treatment, The Varian Edge Radiosurgery System targets cancer with pinpoint accuracy, in as little as one treatment, with less harm to surrounding tissue. Multidisciplinary Care The Department of Radiation Oncology is part of an integrated cancer program at White Plains Hospital that features regular, disease-specific, multidisciplinary tumor boards for a variety of malignancies, including cancers of the blood, breast, lungs, gastrointestinal tract, brain, urinary tract and female reproductive systems. Dr. Stevens is Chair of the White Plains Hospital Institutional Review Board for clinical research and a surveyor for the National Accreditation Program for Breast Centers. M D N E W S . C O M /// M D N E W S L O W E R H U D S O N / B R O N x ■ 2 018 0 7

